Fundraising Fox
/Companies
Sign in

DELiver Therapeutics

Houston, US · 1 known investors

Find your way into DELiver Therapeutics

Sign up to see every warm intro you have to DELiver Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the DELiver Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

DELiver Therapeutics develops small molecule and peptide therapeutics using high-throughput DNA encoded library (DEL) drug screening to address challenging and previously "undruggable" targets in clinical medicine, with a focus on tyrosine kinase targets. Its R&D facilities are located at K2Bio in Houston.

BiotechDeep TechHealthtechLongevityMedical Devices

Founders & leadership

KSKevin Slawin
Kevin SlawinFounderKevin Slawin is a prostate cancer surgeon and biotech entrepreneur who co-invented the Prostate Health Index diagnostic test and cell therapy technologies including GoCAR-T. He founded or co-founded multiple biotech companies including Bellicum Pharmaceuticals, which completed an IPO in 2014, and currently leads DELiver Therapeutics, Eos SENOLYTIX, Phoenix SENOLYTIX, and PrintBio.

Investors · 1

Frequently asked questions

What does DELiver Therapeutics do?
DELiver Therapeutics develops small molecule and peptide therapeutics using high-throughput DNA encoded library (DEL) drug screening to address challenging and previously "undruggable" targets in clinical medicine, with a focus on tyrosine kinase targets. Its R&D facilities are located at K2Bio in Houston.
Who founded DELiver Therapeutics?
DELiver Therapeutics was founded by Kevin Slawin.
Who are DELiver Therapeutics's investors?
DELiver Therapeutics's investors include Rapha Capital Management, LLC.
Where is DELiver Therapeutics headquartered?
DELiver Therapeutics is headquartered in Houston, US.